Numerous studies have demonstrated that PPARγ acts as a tumor suppressor by activating the pro-apoptotic gene TP53 and blocking the cell cycle through the overexpression of p21 in colon, lung, pancreatic, prostate and breast cancer cell lines [170,171,172,173,174]. This evidence concerns the gene TP53 and neoplasm.